A phase II study of palonosetron to prevent nausea and vomiting induced by chemotherapy in haematological malignancies.
Latest Information Update: 04 Jun 2021
At a glance
- Drugs Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 02 Jun 2021 Status changed from recruiting to completed.
- 15 Jun 2013 New trial record